Old Articles: <Older 1701-1710 Newer> |
|
The Motley Fool March 30, 2007 Jeremy MacNealy |
Fool on Call: Why Nike's a Champ The sportswear giant reveals part of its European turnaround strategy. Investors, take note. |
Chemistry World March 29, 2007 |
Sanofi-Aventis and Oxford BioMedica Enter Licensing Agreement UK biotech firm Oxford BioMedica has licensed its leading cancer drug, TroVax, to France's Sanofi-Aventis. |
BusinessWeek April 9, 2007 Jason Bush |
Russia's New Deal The Kremlin is pumping money into education, housing, and health care. |
The Motley Fool March 29, 2007 S.J. Caplan |
Auf Wiedersehen, Amvescap? UK asset management firm Amvescap loses 16 money managers to Deutsche Bank. While Amvescap has tried to plug its holes, its American depositary shares have tumbled 8.3%. |
The Motley Fool March 29, 2007 Dale Baker |
Mapeley Calling A new twist in office property investing, UK-style. With less than two years as a public company, Mapeley Ltd.'s modest $2.2 billion market cap puts it in the junior varsity ranks, but its business model holds a lot of promise. |
Inc. April 2007 Kendig Kneen |
How I'm Adjusting to the European Market How a manufacturer of scrap processing equipment re-engineered its product to sell in Europe. |
Inc. April 2007 Mike Hofman |
How I Did It: Howard Dahl, President and CEO, Amity Technology Negotiating with commissars. Bartering for payment. Surviving the crash of the ruble. Howard Dahl has found doing business in the former Soviet Union to be intellectually exhilarating and spiritually rewarding. |
Chemistry World March 27, 2007 Arthur Rogers |
Harmonising Pharmaceutical Quality Worldwide A new headquarters incorporating 1800 square meters of laboratory space was inaugurated recently, offering state-of-the-art accommodation and technical facilities for the European Pharmacopoeia's 160 personnel, of whom half are scientists. |
The Motley Fool March 26, 2007 Rich Smith |
Foolish Forecast: Where's Wimm-Bill-Dann? The Russian dairy king is set to report its fourth-quarter and full-year 2006 results. Investors, here is what you can expect to see. |
The Motley Fool March 23, 2007 Rich Smith |
Mobile TeleSystems Surprises, Delights Mobile TeleSystems bested quarterly revenue estimates by growing 35% to $1.8 billion. About the only metrics to decline were those for customer churn in MTS' largest market, Russia. Investors, take note. |
<Older 1701-1710 Newer> Return to current articles. |